Background
The damaging effects to the fetus of maternal alcohol consumption during pregnancy have been recognised and commented on since as long ago as the Ancient Greek philosophers. 4 There are references in the Bible relating to the ill effects of alcohol in pregnant women: 'You will conceive and give birth to a son. Now then drink no wine or fermented spirit…'. 5 While it could be argued that these quotes are taken out of context as the actual pathology of the damage was not known in the past, they do represent a long historical recognition that the effects of alcohol on a developing fetus can be harmful.
Calhoun and Warren 4 describe the modern history of FAS, beginning with a case series published by Paul Lemoine in 1967. 6 A French paediatrician and his midwifery colleagues reported on 127 cases of children who had all been exposed to alcohol prenatally, and their later difficulties. The study did not, however, set out the diagnostic features required to identify the condition. The article that led to a change in the recognition and definition of the condition was published in 1973 in The Lancet by Smith and Jones. They reported on children living on an American Indian reserve who all presented with consistent, common and recognisable features, which they called fetal alcohol syndrome. 7 All of the children's mothers had consumed high levels of alcohol during pregnancy. Smith and Jones set out a series of criteria which formed the basis for the development of diagnostic criteria for FASD.
The publication of Smith and Jones' articles and an increasing recognition of the condition generated a great deal of interest in FAS. Case studies considering the presentation of behavioural difficulties, neurological damage and physical characteristics of the disorder were published. 8 Further, it was becoming clearer that alcohol could affect the brain without resulting in the distortions of facial features attributed to FAS. This led to a debate as to whether the term fetal alcohol effect (FAE) was a more accurate representation of the condition. 9 Insights were obtained from both human examination and animal studies. It was through animal studies that perhaps our greatest understanding about the effects of alcohol during pregnancy were achieved, both from a pathological point of view, but also in clarifying the teratogenicity of alcohol. By using multiple animal models, allowing controlled experiments not possible in humans for ethical reasons, it became possible to begin to identify pathological processes, confirm cognitive profiles and explore possible therapeutic interventions. 10 The Institute of Medicine (IOM) defined a set of criteria in 1996 for classifying the disorder. It was also recognised that prenatal exposure to alcohol could present with a spectrum of difficulties that would vary among individuals. 4 The term FASD came into wider use towards the end of the 1990s, superseding the term FAE.
Fetal alcohol spectrum disorders: is it something we should be more aware of?
education dIagnostIc Issues In fas and fasd
The diagnostic elements of FAS are made up of three facial features (short palpebral fissures, elongated and flattened philtrum and a thin upper lip vermillion), preand postnatal growth deficits (below the tenth percentile), neurocognitive deficits and a history of maternal alcohol consumption during pregnancy. It is only in the case of FAS that confirmation of alcohol consumption is not required for the diagnosis. 1, 2 Timing is also important for diagnosis. When a child is still very young, features such as brain damage or developmental delay may not be obvious, while even at birth there may be signs of the distinct facial features, growth problems and evidence of maternal alcohol exposure. However, without the central nervous system (CNS) deficits, which are not always obvious at birth, a diagnosis of FAS is not valid. Despite this, a possible diagnosis, in anticipation of potential cognitive findings as a child grows older, should be noted and followed up.
While there is general agreement over the diagnostic features of FAS, debate continues over specific criteria. The cut-off figure used for palpebral fissure length for example is different across several diagnostic frameworks.
2,11 Table 1 summarises the similarities and differences between the four main diagnostic frameworks in current practice.
The main difference between the groups remains whether or not the cut-off for palpebral fissure length should be the tenth or the third percentile. In the UK, ninth and second percentiles are now more commonly used. The difficulty in reaching agreement relates to the sensitivity and specificity of this cut-off measurement. A sensitivity test will pick up more of the true positive cases, while a specificity test will rule out more of the incorrect cases. The best test is one that has both high sensitivity and high specificity. Unfortunately, in most cases one tends to be higher than the other, leading to the discrepancies between the different diagnostic groupings and uncertainty about the reliability, accuracy and usefulness of the tests. Astley for example compared two diagnostic groupings, finding discrepancies between the methods used and the subsequent results obtained.
11
These discrepancies highlight the inherent need for local norms for diagnosis to be agreed and established. The Canadian Guidance, developed by the Canadian Advisory group on FASD, is increasingly used as the best overview of all current guidelines. 12 
overlappIng symptoms
One of the other difficulties in diagnosing FAS and FASD is because many of the established symptoms of FAS and FASD tend to be characteristic rather than discriminating. A characteristic symptom is one that is commonly seen in the disorder, however it may also be found as the result of other disorders. Discriminating symptoms occur uniquely as the result of a specific disorder. As FASD cases present mainly, if not wholly, with characteristic symptoms, it is only by exclusion of other disorders through genetic testing and through confirmation of alcohol consumption, that a reliable diagnosis can be established. Unfortunately, the amount and quality of information necessary to conduct such a careful differential diagnosis is frequently missing. In his editorial, Goddlett noted the establishment of a collaborative initiative who are attempting to overcome many of these issues and to bring consistency in diagnosis and management to the field of FASD. 13 There has been much speculation and debate about the relationship between FASD and primarily attention deficit hyperactivity disorder (ADHD), but also its links with autism. Various types of relationships have been suggested, from direct causality to separate but overlapping disorders 14, 15 but as yet agreement about them 16 We believe the association between the two appears to be more than what might be attributed to chance. Therefore we believe, as others have for similar conditions, 17 that more research is needed in order to establish the relationship between the phenomenology and the underlying neurological pathology.
epIdemIology
The original IOM criteria were used in various epidemiological studies of FAS and FASD but they were refined in 2006, 2 leading to wide variations in the reported prevalence rates from those originally stated. 18, 19 Other problems were found with other studies. An investigation by May et al. for example in Lazio, Italy, showed that the prevalence rates of the full spectrum of FASD was estimated at 35 people per 1,000. 20 Unfortunately, despite actively recruiting study participants (proactively identifying cases rather than passively waiting for them to be reported) in order to establish prevalence, the study group moved people between diagnostic groupings based on clinical review rather than strict adherence to the study design. This led to criticism of the study, most specifically in regards to the validity of the results. 20 A later study by Petkovic and Barisic, using similar methodology as the May study, but without the same limitations and criticisms, showed similar findings in a population of school-aged children. 21 They actively recruited participants in two regions of Croatia (over 1,200 people). This study showed an overall prevalence rate of FAS and partial FAS of 40.77/1,000. 21 However these studies have yet to be widely replicated by other groups. The suggestion from studies thus far is that the prevalence rate in the full population is higher than previously thought. Table 2 summarises studies that used the same methodology, however the actual rate in many parts of the world is still unclear. The results however continue to represent the best available estimates of prevalence.
In the UK there have been no actively recruited studies. This is unfortunate, as passive surveillance studies have been shown to have poor reliability due to the underreporting of the rates of prevalence. A recently published study completed a review of paediatric hospital episode statistics in the UK over a five-year period which showed a progressive increase in the rates, but ultimately they were much lower than expected. 22 The true prevalence in the UK therefore still needs to be established.
alcohol consumptIon and the level of rIsk
Establishing the actual level of alcohol consumed during pregnancy in order to accurately diagnose the disorder is challenging but necessary. Despite attempts to improve awareness of the need for this information, problems persist partly because alcohol exposure is not often recorded in the medical records of children or mothers. 22 It has also been reported that the recall of alcohol consumption amounts is poor. 23 Different ways of improving the recording of what women drink during pregnancy continue to be researched. Existing methods range from the use of specialist screening tools such as the T-ACE questionnaire or the Alcohol Disorders Identification Test (Audit-C) to the use of specific biomarkers. 1, 14 The screening tools raise concerns because they rely on honest reporting. To circumvent these concerns, a search for biomarkers such as free fatty ethyl esters in meconium can be done. 1, 24, 25 Unfortunately, these biomarkers only pick up second and third trimester alcohol consumption. There are also ethical considerations around the use of biomarkers in the absence of informed consent, particularly since the level of risk has not been established. 26 The implications of this on the wider 'drinking during pregnancy' debate must also be considered.
Another challenge to collecting data on individual alcohol consumption during pregnancy is a lack of a clear definition of what is considered to be a 'safe' amount of alcohol. 27, 28 Studies have shown dose-response relationships between levels of alcohol consumption and harm: higher levels of alcohol exposure were found to cause the most obvious neurodevelopmental problems; 27,29-31 lower levels of alcohol exposure are more difficult to assess, with some studies reporting no clear differences compared to a non-exposed group, 29, 30, [32] [33] [34] [35] [36] [37] [38] while others continue to suggest possible effects of even low exposure levels. 31, 35, [39] [40] [41] As such, the levels of individual risk remain uncertain. 
education
Perhaps unsurprisingly, given the difficulties stated above, the advice about drinking alcohol during pregnancy currently differs from country to country. 42 In the UK for example, women are advised to avoid alcohol consumption if possible and, if they do drink alcohol, to consume no more than one to two drinks in a single sitting. However, the definition of how much alcohol constitutes one to two drinks is often confusing and unclear. Combined with the public's limited understanding of the scientific conclusions about the risks of drinking alcohol during pregnancy, this creates a dangerous situation. 28 
awareness and understandIng of fasd In the general populatIon
Internationally and more specifically in the UK, conflicting evidence regarding the effects of alcohol during pregnancy has seemingly led to inconsistent understanding of FASD in both professionals and the public. [43] [44] [45] [46] [47] [48] [49] [50] This has implications for the management and the prevention of the disorder. The development of a consistent public health strategy remains a challenge, particularly when the condition is one that, unlike many others, can be entirely prevented simply by not consuming alcohol while pregnant. As such, it has been argued that FASD constitutes a public health disorder that requires directed prevention strategies.
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The lack of consistent guidelines and the subsequent confusion over health strategy means that providing support for individuals and families can be challenging. This increases the health burden and stress faced by those with FASD and their families. [53] [54] [55] [56] [57] [58] The publicly funded health and social care system in the UK is accessible by all and therefore may well offer better support to those with FASD and their families compared to countries in which access is more limited, although budget limitations may well mean the opposite is also true. The situation is currently unclear and requires clarification.
evIdence from anImal studIes on the effects of alcohol
Part of the difficulty of finding evidence that supports the labelling of alcohol as a teratogen relates to the ethical and practical aspects of conducting this research. Ethically, it is not possible to conduct controlled human experiments into the risks of alcohol during pregnancy. Population-based studies are inherently biased by confounding factors. For example, alcohol consumption by the mother is known to cause prematurity, 59 yet prematurity itself is also known to cause cognitive deficits regardless of what may have caused it. 60 Further, much of the population-based work is subject to bias, especially in terms of recall of alcohol consumption. 61 To overcome this and statistically correct for these confounding factors, large numbers of research participants are required.
Alternative methods for researching this subject have been suggested (such as the use of natural experiments) but have yet to be widely implemented. 62 Instead, animal studies have formed the basis for providing the basic pathology of FASD. Hannigan summarised the research undertaken in the years prior to his review in 1996. 63 He looked at the data collected using animal research, including evidence about dose-response rates, timing of exposure and risk, neuro-anatomical and neuro-behavioural dysfunctions and offered an insight into potential future treatments. Despite the availability of this evidence, the report concluded by suggesting that much more work was still needed.
Sulik's study helped identify the dose-dependent effect of alcohol on the development of facial features and clarified how the timing of alcohol exposure affects subsequent fetal development by identifying a risk period during weeks three to four of gestation. She also considered factors that may alter alcohol teratogenesis between individuals. 64 Her research has implications for humans in that, in the UK at least, women are drinking more than in the past and the patterns of this alcohol consumption both in terms of who is consuming alcohol and where it is consumed have changed. 65 More women are consuming alcohol at levels that are associated with the levels of risk identified in the animal studies. 66 The timing of pregnancy recognition is therefore crucial in helping women to refrain from alcohol consumption during the earliest period in the pregnancy when facial features of the fetus are most susceptible to damage. Many women will consume alcohol until pregnancy is detected, usually between the first and second missed period. Once pregnancy is confirmed, however, around 67% of women in the UK will significantly reduce or stop drinking. 23 As a result, it seems likely that for some fetuses, damage to the facial features may occur, but later development may continue, unaffected by alcohol, leading to the subsequent unhindered development of the brain and body. This in itself has implications for relying solely on facial features for the diagnosis of FAS and confirms the importance of the cognitive features in the diagnosis. It is clear from the literature on animal studies that the risks of alcohol consumption during pregnancy exist during all trimesters, not just the first. 63, 64 Ongoing brain development in the second and third trimesters means that public health advice regarding alcohol consumption must also cover these trimesters.
While many have extrapolated the results of the animal studies to the human population, some authors have questioned the methods of animal research and the applicability of the conclusions of the results to humans. Abel argues for example that in some of the animal experiments that refer to 'low blood alcohol concentrations', rather than representing low levels of alcohol education in the bloodstream, this actually describes concentrations that would correspond to high levels of alcohol in a human. He points out that the methods of alcohol delivery, such as putting animals onto liquid alcohol diets, do not reflect human consumption patterns, making interpretation difficult. A six gram dose of alcohol in a rat for example equates to 27 drinks per day in an average human (where a US drink equated to 1.5 UK units). 32 In their paper, Leichter and Lee confirm that the method of alcohol delivery in animal studies represents a confounding factor in their interpretation. 67 Despite these issues, animal studies remain the only way to ethically study the effects of alcohol on fetuses and confirm its teratogenicity. By showing consistent findings in multiple animal models it is possible to make comparisons to the human findings from populationbased research. Cudd describes the strengths and weaknesses of different models of exploration, concluding that substantial progress in the field will require the judicious use of multiple scientific approaches using different animal systems. (Table 3) . 69 Rasmussen carried out a systematic review of executive function (the set of cognitive abilities that control and regulate other abilities and behaviours) and working memory 70 and confirmed these two areas of deficit found in experimental studies contributed to the difficulties in function seen in affected individuals. Rasmussen's review complimented much of the work of Matteson and colleagues, who looked at IQ and its relationship to facial features 71 as well as how executive functioning in this group was affected by alcohol. 72 They contributed much to the understanding of how the condition presents. Others, such as Burden and colleagues, have shown how attention and pressure of time to complete a task can affect those with FASD by studying working memory and processing speed. 73, 74 Sampson and colleagues have further highlighted that pressure and time affect the accuracy of an individual's results on cognitive tests. Roebuck et al. looked at the importance of the corpus callosum damage caused by maternal alcohol consumption and the impact that this has on cognitive presentation and the ability of those affected to link information between cerebral hemispheres. 75 All of these findings have implications for the management of FASD, by establishing that performance can be improved by reducing external expectations and time pressures on those affected. 76 Increased understanding of the condition and the correlation of psychometric findings with neuro-imaging studies has led to a more refined profile. 77 Using data from two sites of a multi-site FASD international project, Matteson et al. found that executive functioning and spatial processing were especially sensitive to prenatal alcohol exposure. 78 The remaining challenge is to identify how these cognitive profiles can help to integrate and establish management strategies on the basis of individual diagnostic profiles. Kodituwakku for example, has argued that in reality, a broader framework of understanding and subsequent intervention is needed in order to bring together the cognitive profiles to allow better management of this condition. 79 
secondary dIsaBIlItIes
As a child grows into an adult, the secondary disabilities associated with FASD are increasingly recognised. Secondary disabilities are defined as those caused by inadequate recognition and support management of the primary disability. Streissguth et al. published a list of secondary disabilities from a long-term cohort study where participants were followed up for over 30 years. 80, 81 These deficits are summarised in Table 4 . Steinhaussen and Spohr have also conducted a long-term follow-up study showing the difficulties that continue into adulthood. 82 While support on an individual level has been shown to lead to a better overall outcome, a lack of that same support is known to lead to significant 83 Unfortunately, as the report was based on a very small number of participants, the findings were not widely accepted. The data, however, were corroborated in a study by Barr et al in 2006 . In a larger series they showed high rates of mental illness. The larger sample also allowed statistical correction for confounding factors influencing the outcomes. 84 In addition, it has been found that people with FASD who also suffer with mental illness have been associated with higher rates of suicide. 85 Larger scale epidemiological studies have increasingly been used to look at the wider impact of prenatal alcohol exposure on both developmental and mental health presentation. Work conducted by Kelly et al. for example, showed that, in a sample of 11,513 people, low levels of alcohol exposure had less of an impact on socioemotional or cognitive outcomes. They did however show a clear relationship between higher levels of alcohol exposure and cognitive deficits. 30 This was in contrast to findings by Sayal et al. who found that girls aged nine were more likely to suffer mental health problems even at maternal alcohol consumption levels of less than one UK unit a week (in a sample of 8,046 people). 31 At present these contrasting findings leave almost as many questions as answers. More research will be required to clarify these issues.
conclusIons
Recognising and managing FASD is a challenge in the UK. Discrepancies in the scientific literature continue to raise questions about the condition, but there is general agreement that FASD will demand significant preventive, medical and social care resources in the future. Overall, better training on FASD and its impact is needed for all professionals working in the fields of health, social work, criminal justice and education. If the situation in the UK is to improve, with a decrease in the number of people with FASD achieved, the cause and impact of the condition must be clarified and widely and consistently communicated to professionals and the public. While some changes have already begun to happen, there is a great deal left to do.
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